FMD vaccines: reflections on quality aspects for applicability in European disease control policy.

Last updated on 22-8-2019 by Anonymous (non vérifié)

Peer reviewed scientific article



Most foot-and-mouth disease (FMD) vaccines used around the world are inactivated vaccines for prophylactic or emergency use, generally manufactured by the same basic methodology outlined in the OIE Manual and, for Europe, in the European Pharmacopoeia, and for the EU Member States in compliance with Directive 200⅛2/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products as amended by Directive 2004/28/EC. Most of the requirements that apply to all immunological veterinary medicinal products apply equally to FMD va…

Associated health topics:

QR code

QR code for this page URL